Historically, the healthcare sector has provided a pretty good hedge at a time when other public relations specialties are fluctuating wildly—during the dot-com bust, for example, healthcare firms continued to flourish—so it’s not difficult to see why Peter Chadlington’s Huntsworth Group has devoted considerable time and money over the past couple of years in building an international healthcare capability, with his Huntsworth Health operation offering a broad range of capabilities including advertising, medical education, research, branding, public relations and digital.
Launched formally in London in 2005, Huntsworth Health expanded aggressively in early 2007 with the acquisition of two American firms—medical advertising and public relations agency Dorland and
Huntsworth Health is led by global chief executive David Rowley, a 20-year veteran of both corporate and consultancy positions within the pharmaceutical industry, and most recently founder of The Pharmaceutical Brand Consultancy; executive creative director Marcus Perry, formerly of PBC Group; and
The firm already works for many of the world’s top 50 pharmaceutical companies, with sanofi-Aventis, Pfizer, Baxter and Novartis Vaccines as its largest clients. “The strategic insight Huntsworth Health offered for our recent communications campaign took our thinking to a new level.” says Jeff Bolton, a senior brand manager for Pfizer Endocrine Care. “The resulting programmes it delivered were innovative, strategically aligned and delivered in a timely manner. They are a professional organisation and a pleasure to work with.”
Notable achievements this year included the pan-European cardiovascular pre-launch plans for Sevikar and Otsuka.
In addition to its